Recherche - Université de Picardie Jules Verne Accéder directement au contenu

Filtrer vos résultats

6 Résultats
Structure : Identifiant HAL de la structure : 210675

LBA33 5-year overall survival (OS) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) treated with xevinapant + chemoradiotherapy (CRT) vs placebo + CRT in a randomized, phase II study

J. Bourhis , C. Le Tourneau , B. Calderon , L. Martin , C. Sire , et al.
Annals of Oncology, 2022, 33, pp.S1400. ⟨10.1016/j.annonc.2022.08.030⟩
Article dans une revue hal-03911292v1

Triage Scoring System Based on Early Post-Transplant Complications for Patients with Myelodysplastic Syndrome Requiring ICU after Allo-HCT: An SFGM-TC Study

Federico Garnier , Alain Duhamel , Ibrahim Yakoub-Agha , Alexis Caulier , Elodie Drumez , et al.
Article dans une revue hal-03605967v1

Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French network

Laurence Schenone , Caroline Houillier , Marie Laure Tanguy , Sylvain Choquet , Kossi Agbetiafa , et al.
Bone Marrow Transplantation, 2022, 57 (6), pp.966-974. ⟨10.1038/s41409-022-01648-z⟩
Article dans une revue hal-03703797v1

Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort

Edmond Chiche , Ramy Rahme , Sarah Bertoli , Pierre-Yves Dumas , Jean-Baptiste Micol , et al.
Blood Advances, 2021, 5 (1), pp.176-184. ⟨10.1182/bloodadvances.2020003159⟩
Article dans une revue hal-03605963v1

Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial

Yungan Tao , Xu-Shan Sun , Yoann Pointreau , Christophe Le Tourneau , Christian Sire , et al.
European Journal of Cancer, 2023, 183, pp.24-37. ⟨10.1016/j.ejca.2022.12.015⟩
Article dans une revue hal-04002440v1

Pooled Fecal Allogenic Microbiotherapy for Refractory Gastrointestinal Acute Graft-Versus-Host Disease: Results from the Early Access Program in France

Florent Malard , Michael Loschi , Thomas Cluzeau , Faezeh Legrand , Jean-Baptiste Mear , et al.
Blood, 2022, 140 (Supplement 1), pp.276-278. ⟨10.1182/blood-2022-163340⟩
Article dans une revue hal-04020905v1